ESC 365 - Significant reduction of insulin dose after administration of sacubitril/valsartan in the patient with heart failure due to dilated cardiomyopathy, a case report.

HFA Premium Access

Significant reduction of insulin dose after administration of sacubitril/valsartan in the patient with heart failure due to dilated cardiomyopathy, a case report.

Session: Poster Session 1 - Clinical Cases

Topic: Treatment

Speaker: Doctor M. Hegarova (Prague, CZ)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Marketa Hegarova

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

1 presentation

0 follower

28 more presentations in this session

A rare case of atrial septal defect with mitral valve papillary fibroelastoma

Speaker: Mr A. Filias (Patras, GR)

Belated diagnosis of non-ischemic dilated cardiomyopathy in a patient with previous bypass surgery

Speaker: Doctor M. Bazmpani (Thessaloniki, GR)

Successful percutaneous transcatheter closure of a prosthetic mitral paravalvular leak causing heart failure

Speaker: Associate Professor T. Habon (Pecs, HU)

Have we found the Holy Grail in Heart failure with reduced ejection fraction? - First experiences with sacubitril/valsartan among heart transplant candidates

Speaker: Doctor B. Muk (Budapest, HU)

Reversible left bundle branch block after sacubitril/valsartan in patient with severe heart failure

Speaker: Doctor P. Lin (Hsinchu, TW)

Access the full session

Poster Session 1 - Clinical Cases

Speakers: Doctor M. Hegarova, Mr A. Filias, Doctor M. Bazmpani, Associate Professor T. Habon, Doctor B. Muk...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources